Search

Infliximab infusion reactions

“According to the infusion reaction data reviewed, scheduled vital sign assessment did not detect any infusion reactions and may not be necessary for the purpose of monitoring patients during infusions for early detection of infusion reactions” Casey (2022).

Read More »

Y-site infusion compatibility

“This review provides useful and reliable information on the compatibility of antimicrobials administered as Y-site infusion with other drugs commonly used in the critical setting” Nunez-Nunez et al (2022).

Read More »

IV fluid management

“A clear need for more structured information on IV fluids was identified. Both physicians and nurses struggle with fluid therapy” Wuyts et al (2022).

Read More »

Cefepime prolonged infusions

“No difference in risk of ADEs including AKI was seen with cefepime PI in pediatric CF patients. Clinical outcomes were not significantly different between groups, but sample size may have limited comparison” Imburgia et al (2022).

Read More »

Vascular Access and IV Therapy Resource

"IVTEAM is a global vascular access and infusion therapy resource that provides daily updates for clinical teams. Our updates ensure health care professionals can easily keep up to date with the most relevant evidence related to vascular access and infusion therapy."
IVTEAM
IVTEAM

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey